Cargando…
Retraction: Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219771/ https://www.ncbi.nlm.nih.gov/pubmed/32401776 http://dx.doi.org/10.1371/journal.pone.0233436 |
Ejemplares similares
-
Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer
por: Deharvengt, Sophie, et al.
Publicado: (2012) -
Retraction: A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells
Publicado: (2019) -
Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor
por: Yang, Hsin-Han, et al.
Publicado: (2021) -
Retraction of “Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice”
por: Leng, Weibing, et al.
Publicado: (2020) -
Retraction: SOX2 Enhances the Migration and Invasion of Ovarian Cancer Cells via Src Kinase
Publicado: (2023)